We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Parliamentary Report Rips India’s CDSCO on Drug Approvals, Colluding With Industry
Parliamentary Report Rips India’s CDSCO on Drug Approvals, Colluding With Industry
May 10, 2012
As many as 33 new drugs approved for use in India between January 2008 and October 2010 — roughly one a month — never underwent clinical trials, according to a scathing parliamentary assessment of the Central Drugs Standard Control Organization (CDSCO) and its drug approval process.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor